Inverse Abasic CNA CPG Low Bulk Density
CPG for the incorporation of an inverse (5' to 3') abasic (no nucleobase on the sugar) within an oligonucleotide.
CPG for the incorporation of an inverse (5' to 3') abasic (no nucleobase on the sugar) within an oligonucleotide.
Phosphoramidite for the incorporation of a ribo abasic spacer internally or at the 5' end of an oligonucleotide.
Phosphoramidite for incorporation of a 9-atom spacer (TEG, triethylene glycol) internally or at the 5' end of an oligonucleotide.
CPG for incorporation of a C3 spacer at the 3' end of an oligonucleotide.
CPG for incorporation of a C6 spacer at the 3' end of an oligonucleotide.
CPG for the incorporation of an inverse (5' to 3') abasic (no nucleobase on the sugar) within an oligonucleotide.
CPG for incorporation of a C16 spacer at the 3' end of an oligonucleotide.
Phosphoramidite for incorporation of an 18-atom spacer (HEG, hexaethylene glycol) internally or at the 5' end of an oligonucleotide.
CPG for incorporation of a C2 spacer at the 3' end of an oligonucleotide.
CPG column for incorporation of a C6 spacer at the 3' end of an oligonucleotide.
Europe, Middle East, and Africa | |
---|---|
UK | +44 1992 470 757 |
Germany | +49 30 5304 2200 |
North America, Latin America | |
Wisconsin, USA | +1 888 575 9695 |
Asia Pacific | |
China | +8621-22509000 |
Singapore | +65 6734 4800 |